Tag: million

Diakonos Oncology Secures $20 Million Investment for Advancing Cancer Treatments

Summary: Diakonos Oncology Corp. closed a $20m private placement of Simple Agreements for Future Equity (SAFE) to develop

Rime Secures $5.5 Million in Seed Investment

Summary: Rime, a San Francisco-based speech tools company, secured $5.5M in Seed funding. The funding round was led

Snorkel AI Secures $100 Million in Series D Funding, Valued at $1.3 Billion

Snorkel AI Raises $100M in Series D Funding, Hits $1.3 Billion Valuation Snorkel AI, a company based in

Unbound Secures $4 Million in Funding

Summary: Unbound, a San Francisco-based company, secured $4 million in funding for its generative AI tools for IT

Vima Therapeutics Secures $60 Million in Series A Investment Round

Summary: Vima Therapeutics, a biotechnology company based in Cambridge, MA, secured $60M in Series A funding led by

Outcomes4Me Secures $21 Million in Funding

Summary: Outcomes4Me, a Boston-based company, secured $21 million in funding led by Salica Investments. The funding will be

Empathy Secures $72 Million in Series C Funding to Drive Growth

Summary: Empathy, a NYC-based lost support and legacy planning technology company, secured $72M in Series C funding. The

Naoris Protocol Secures $3 Million in Strategic Investment

Summary: Naoris Protocol, a quantum-resistant blockchain and cybersecurity company based in Wilmington, DE, secured $3M in funding. The

Start-up Asigna Secures $3 Million in Investment Funding

Summary: Asigna, a smart multisig vault operator for Bitcoin, raised a $3M funding round led by Hivemind Capital

StackHawk Secures $12 Million in Investment

Summary: StackHawk, a San Francisco-based API security platform, secured $12M in additional funding. The funding round was supported

RevenueCat Secures $50 Million in Series C Investment

Summary: RevenueCat, a platform for managing consumer app monetization, raised $50M in Series C funding led by Bain

Fore Biotherapeutics Secures $38 Million in Series D-2 Funding

Summary: Fore Biotherapeutics, a biotherapeutics company based in Philadelphia, secured $38M in Series D-2 financing to develop targeted